Dell Plans Spinoff of $52 Billion Stake in VMware 
 

The personal-computer maker said it intends to use net proceeds from the deal to pay down debt.

 
Thermo Fisher Nears Deal to Buy PPD for More Than $15 Billion 
 

If completed, deal would be the latest tie-up among companies that run clinical trials and provide other services for drugmakers.

 
Johnson & Johnson Vaccine Pause Sparks Scrambles Across Country 
 

Vaccination sites canceled thousands of appointments after U.S. health authorities paused the use of Johnson & Johnson's Covid-19 shots over reports of rare but severe blood clots, while other sites scrambled to switch to another vaccine.

 
Novavax to Participate in Oxford Study Comparing Covid-19 Vaccine Combinations 
 

A Novavax Covid-19 vaccine will be studied in a Phase 2 trial conducted by the University of Oxford "to evaluate the potential for combined regimens that mix vaccines from different manufacturers to achieve immune protection against Covid-19."

 
Coinbase Fetches $85 Billion in Value in Trading Debut 
 

The cryptocurrency exchange is the first major bitcoin-focused company to test the U.S. public market, marking a watershed moment for an industry that began a decade ago as an experiment in digital money.

 
American-JetBlue Alliance Draws Increased Scrutiny From DOJ 
 

The Justice Department has stepped up an antitrust probe of American Airlines's recent partnership with JetBlue Airways, concerned the deal could lead to anticompetitive coordination and inflated fares at certain hubs.

 
Qantas Ramping Up Domestic Capacity Amid Leisure Surge 
 

Australia's No. 1 airline, Qantas Airways Ltd., said it is increasing domestic capacity faster than expected in response to a surge in demand from leisure travelers as coronavirus restrictions ease.

 
Bed Bath & Beyond's Improvement Project Is Far From Finished 
 

The selloff in Bed Bath & Beyond looks overdone considering its unsurprising results, but the retailer still has a way to go to win back confidence.

 
Wall Street Banks Do More With Less 
 

Banks such as JPMorgan Chase and Goldman Sachs are producing huge returns in their Wall Street arms, suggesting that perhaps investors are undervaluing that part of their business

 
Kohl's to Add Directors in Deal With Activist Investors 
 

Three retail veterans will join the board of the department store chain, which has contended with an activist campaign since earlier this year.

(END) Dow Jones Newswires

April 14, 2021 21:15 ET (01:15 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.